Get the Stockscreener App
4.15
8.36%
0.32
Pre-market:
4.17
0.02
+0.48%
Omeros Corporation stock is traded at $4.15, with a volume of 5.10M.
It is up +8.36% in the last 24 hours and up +29.69% over the past month.
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
See More
Previous Close:
$3.83
Open:
$3.95
24h Volume:
5.10M
Relative Volume:
4.46
Market Cap:
$243.16M
Revenue:
-
Net Income/Loss:
$-117.81M
P/E Ratio:
-2.2074
EPS:
-1.88
Net Cash Flow:
$74.30M
1W Performance:
+14.01%
1M Performance:
+29.69%
6M Performance:
-53.68%
1Y Performance:
-20.50%
1-Day Range:
$3.80
$4.45
1-Week Range:
$3.58
$4.52
52-Week Range:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Name
Omeros Corporation
Sector
Industry
Phone
206-676-5000
Address
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.15 | 224.41M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-25 | Initiated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Dec-08-22 | Downgrade | UBS | Buy → Neutral |
| Nov-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-08-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-08-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-21 | Downgrade | Maxim Group | Buy → Hold |
| Oct-01-21 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-27-21 | Initiated | JP Morgan | Neutral |
| Feb-01-21 | Initiated | UBS | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Aug-21-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-14-20 | Reiterated | Maxim Group | Buy |
| May-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-12-18 | Initiated | Seaport Global Securities | Buy |
| Mar-23-18 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-05-18 | Downgrade | Needham | Buy → Hold |
| Nov-08-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| Mar-17-17 | Reiterated | Maxim Group | Buy |
| Mar-17-17 | Reiterated | Needham | Buy |
| Nov-16-16 | Reiterated | Wedbush | Outperform |
| Nov-10-16 | Reiterated | Needham | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Jun-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-02-16 | Reiterated | Needham | Buy |
| Feb-29-16 | Reiterated | Wedbush | Outperform |
| Nov-11-15 | Reiterated | Needham | Buy |
| Aug-18-15 | Reiterated | WBB Securities | Strong Buy |
| Aug-10-15 | Initiated | ROTH Capital | Buy |
View All
Omeros Corporation Stock (OMER) Latest News
Visual analytics tools that track Omeros Corporation performanceFree Risk Adjusted Technical Entry Plan - Newser
How strong is Omeros Corporation company’s balance sheetFree Stock Recommendation From AI Tools - jammulinksnews.com
These Numbers Prove Just How Vibrant The Omeros Corporation (NASDAQ: OMER) Stock Has Been - Stocksregister
Is it the right time to buy Omeros Corporation stockUnlock powerful stock screening techniques - jammulinksnews.com
Is Omeros Corporation a growth stock or a value stockProven strategies for superior portfolio growth - jammulinksnews.com
Real time scanner hits for Omeros Corporation explainedMomentum Stocks with Breakout Potential - Newser
What institutional investors are buying Omeros Corporation stockExplosive earning power - jammulinksnews.com
How to read the order book for Omeros CorporationLong-Term Growth Trend Summary With Confidence - Newser
Trend analysis for Omeros Corporation this week Free Short Term Buy Zone Stock Alerts - Newser
New York State Common Retirement Fund Sells 5,900 Shares of Omeros Corporation (NASDAQ:OMER) - Defense World
What makes Omeros Corporation stock price move sharplyFast-track wealth growth - jammulinksnews.com
When is Omeros Corporation stock expected to show significant growthHigh-yield portfolio picks - jammulinksnews.com
Moving Average Trends for Omeros Corporation Stock: What They Indicate3x Return Stock Radar - Newser
Omeros Corporation (NASDAQ:OMER): When Will It Breakeven? - 富途牛牛
Is Omeros Corporation a Top Dividend Stock to Watch in 2025High Return Potential - Newser
Omeros (NASDAQ:OMER) Earns Buy Rating from D. Boral Capital - Defense World
Omeros announces pricing of $22 million registered direct offering - MSN
FY2025 EPS Estimates for Omeros Cut by Cantor Fitzgerald - Defense World
Traders Purchase High Volume of Call Options on Omeros (NASDAQ:OMER) - Defense World
Omeros Corporation Announces Pricing of $22 Million Registered D - GuruFocus
Omeros (OMER) Announces $22 Million Stock Sale to Polar Asset Ma - GuruFocus
Omeros (OMER) Stock Rating and Price Target Maintained by D. Boral Capital | OMER Stock News - GuruFocus
Omeros Secures $22 Mln In Registered Direct Offering With Polar Asset Management - Nasdaq
Is Omeros Corporation a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
Omeros stock rises after $22 million registered direct offering By Investing.com - Investing.com Canada
Omeros Stock Soars 8.91% on $22M Equity Offering - AInvest
Omeros rises after pricing ~$22M stock offering - MSN
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | OMER Stock News - GuruFocus
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | - GuruFocus
Omeros to raise $22 million in registered direct offering By Investing.com - Investing.com South Africa
Omeros to raise $22 million in registered direct offering - Investing.com India
Omeros Enters Securities Purchase Agreement with Polar - TipRanks
Form 424B5 OMEROS CORP - StreetInsider
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering - The Joplin Globe
Omeros Corporation Stock Analysis and ForecastTremendous growth potential - PrintWeekIndia
What analysts say about Omeros Corporation stockLightning-fast growth - Autocar Professional
What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com
Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser
Omeros Corporation Stock (OMER) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):